Penumbra (PEN) EPS (Weighted Average and Diluted) (2014 - 2026)
Penumbra (PEN) reported EPS (Weighted Average and Diluted) of $0.82 for Q1 2026, down 18.0% year-over-year from $1.0 in Q1 2025, and down 31.67% on a QoQ basis from $1.2 in Q4 2025.
Penumbra (PEN) has 13 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.82 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) fell 18.0% year-over-year to $0.82 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.34 (up 305.61% YoY) and the FY2025 annual result came in at $4.52, up 1155.56% from the prior year.
- EPS (Weighted Average and Diluted) fell to $0.82 in Q1 2026 per PEN's latest filing, from $1.2 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $1.38 in Q4 2023 and bottomed at -$1.55 in Q2 2024.
- The 5-year median for EPS (Weighted Average and Diluted) is $0.48 (2023), against an average of $0.47.
- The widest annual swing landed in 2023, when EPS (Weighted Average and Diluted) surged 10679.63%; it then tumbled 422.92% in 2024.
- Tracing PEN's EPS (Weighted Average and Diluted) over 5 years: stood at $0.1 in 2022, then soared by 1280.0% to $1.38 in 2023, then slumped by 36.96% to $0.87 in 2024, then jumped by 37.93% to $1.2 in 2025, then plunged by 31.67% to $0.82 in 2026.
- Per Business Quant, the three latest PEN EPS (Weighted Average and Diluted) figures stand at $0.82 (Q1 2026), $1.2 (Q4 2025), and $1.17 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 0.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.82 |
| Dec 31, 2025 | 1.20 |
| Sep 30, 2025 | 1.17 |
| Jun 30, 2025 | 1.15 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | 0.87 |
| Sep 30, 2024 | 0.75 |
| Jun 30, 2024 | -1.55 |
| Mar 31, 2024 | 0.28 |
| Dec 31, 2023 | 1.38 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.22 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | -0.06 |
| Jun 30, 2022 | -0.10 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -0.66 |
| Sep 30, 2021 | 0.24 |
| Jun 30, 2021 | 0.25 |
| Mar 31, 2021 | 0.32 |
| Dec 31, 2020 | 0.10 |
| Sep 30, 2020 | -0.24 |
| Jun 30, 2020 | -0.34 |
| Mar 31, 2020 | 0.04 |
| Dec 31, 2019 | 0.27 |
| Sep 30, 2019 | 0.32 |
| Jun 30, 2019 | 0.46 |
| Mar 31, 2019 | 0.30 |
| Dec 31, 2018 | 0.18 |
| Sep 30, 2018 | -0.55 |
| Jun 30, 2018 | 0.37 |
| Mar 31, 2018 | 0.15 |
| Dec 31, 2017 | 0.25 |
| Sep 30, 2017 | 0.01 |
| Jun 30, 2017 | -0.05 |
| Mar 31, 2017 | -0.10 |
| Dec 31, 2016 | -0.08 |
| Sep 30, 2016 | 0.35 |
| Jun 30, 2016 | 0.09 |
| Mar 31, 2016 | 0.07 |
| Dec 31, 2015 | 0.05 |
| Sep 30, 2015 | 0.03 |
| Jun 30, 2015 | -0.11 |
| Mar 31, 2015 | 0.07 |
| Dec 31, 2014 | 0.01 |
| Sep 30, 2014 | -0.25 |
| Jun 30, 2014 | 0.01 |
| Mar 31, 2014 | 0.04 |